The linguist Lorenza Mondada, Professor of General and French Linguistics at the University of Basel, has been awarded an honorary doctorate by the Faculty of Arts and Sciences at Linköping University in Sweden.
A new method enables genes in living T-cells in mice to be modified quickly and efficiently. It makes use of plasmids, a tried-and-tested method of genetic engineering. Researchers from the University of Basel reported these findings in the Journal of Immunology.
Last year, the Swiss biophysicist Dubochet, along with two other scientists, was awarded the Nobel Prize in Chemistry for developing cryo-electron microscopy. In a symposium, Jacques Dubochet and two of his long-time colleagues will provide fascinating insights into this technology.
TEDxBasel, a regional annual conference for inspiring ideas, will bring together leading thinkers, social entrepreneurs and change makers from the Basel region on May 26. We are giving away ten free tickets for the event at Musical Theater Basel.
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver and can also serve as a biomarker for the diagnosis and prognosis of liver cancer.
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of living zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases.
A new summer internship at the Biozentrum of the Univerity of Basel enables Bachelor students in the sciences to immerse themselves in cutting-edge research projects for up to nine weeks.
Researchers at the Swiss Tropical and Public Health Institute and the University of Basel made an important step toward a deeper understanding of how malaria blood stage parasites turn the switch to become transmissible to other humans.
A newly-discovered hereditary mutation is responsible for an increased production of erythropoietin (EPO) in the blood. This mutation causes a messenger RNA (mRNA) that is not normally involved in the formation of proteins to be reprogrammed so that it produces EPO, thus abnormally increasing the number of red blood cells.
